ACBNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
AURORA CANNABIS INC
Financials through Q4 FY2025, quarter ended Mar 31, 2025Last filing: 40-F on Jun 11, 2026
$3.96−0.03 (-0.75%)
Close on Oct 19, 2026
Share price
−$1.28 (−24.43%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
AURORA CANNABIS INC grew revenue 55.1% to C$343.29M over fiscal 2025.
Revenue
C$343.29M
+55.1% vs. a year earlier
Operating income
C$4.95M
TTM Q4 2025
EPS, diluted
0.04 CAD
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Mar 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- C$343.29M
- EPS, diluted
- 0.04 CAD
Valuation needs the share price. It fills in once daily prices are connected and converted from CAD.
Seven years at a glance
Fiscal years 2017 to 2025, CAD
Revenue
C$343.29M+55.1% YoY
Gross profit
C$187.61M+783.9% YoY
Operating income
C$4.95M
Net income
–
EPS, diluted
0.04 CAD
Free cash flow
–
Reported period